Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,755 | 89 | 97.3% |
| Education | $48.84 | 1 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $555.24 | 42 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $431.72 | 23 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $128.74 | 3 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $122.58 | 6 | $0 (2023) |
| Alkermes, Inc. | $99.75 | 1 | $0 (2022) |
| Axonics, Inc. | $94.56 | 1 | $0 (2024) |
| Amgen Inc. | $72.58 | 2 | $0 (2021) |
| ITI, Inc. | $66.19 | 2 | $0 (2023) |
| Alnylam Pharmaceuticals Inc. | $55.56 | 1 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $51.96 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $497.64 | 18 | ABBVIE INC. ($136.99) |
| 2023 | $334.98 | 15 | Teva Pharmaceuticals USA, Inc. ($111.37) |
| 2022 | $527.03 | 27 | ABBVIE INC. ($152.51) |
| 2021 | $444.18 | 30 | AbbVie Inc. ($206.92) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $55.56 | General |
| Category: Genetic Disease | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Respiratory | ||||||
| 06/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $51.96 | General |
| Category: Cardio-renal | ||||||
| 04/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Respiratory | ||||||
| 04/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $94.56 | General |
| Category: Urology | ||||||
| 04/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Respiratory | ||||||
| 03/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.44 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), FARXIGA, BREZTRI | Food and Beverage | In-kind items and services | $53.93 | General |
| Category: Respiratory | ||||||
| 01/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.21 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: PSYCHIATRY | ||||||
| 10/12/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Respiratory | ||||||
| 10/09/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $96.37 | General |
| Category: Central Nervous System | ||||||
| 08/31/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Respiratory | ||||||
| 07/17/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 11 | $2,417 | $426.60 |
| 2022 | 3 | 57 | 65 | $14,513 | $4,468 |
| 2021 | 3 | 52 | 56 | $55,271 | $3,438 |
| 2020 | 4 | 85 | 88 | $103,495 | $6,464 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 11 | 11 | $2,417 | $426.60 | 17.6% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 17 | 18 | $9,076 | $2,107 | 23.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 29 | 36 | $1,620 | $1,475 | 91.0% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 11 | 11 | $3,817 | $886.19 | 23.2% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 21 | 21 | $37,846 | $2,255 | 6.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 14 | 14 | $17,215 | $1,109 | 6.4% |
| 81002 | Urinalysis, manual test | Office | 2021 | 17 | 21 | $210.00 | $73.08 | 34.8% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 34 | 36 | $63,252 | $4,092 | 6.5% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 24 | 24 | $28,632 | $1,781 | 6.2% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 16 | 17 | $10,676 | $528.79 | 5.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 11 | 11 | $935.00 | $61.60 | 6.6% |
About Carol Holder, CRNP
Carol Holder, CRNP is a Nurse Practitioner healthcare provider based in Union Springs, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1184803066.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Carol Holder, CRNP has received a total of $1,804 in payments from pharmaceutical and medical device companies, with $497.64 received in 2024. These payments were reported across 90 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,755).
As a Medicare-enrolled provider, Holder has provided services to 205 Medicare beneficiaries, totaling 220 services with total Medicare billing of $14,796. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Union Springs, AL
- Active Since 10/29/2007
- Last Updated 08/05/2014
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184803066
Products in Payments
- VRAYLAR (Drug) $435.18
- BREZTRI (Drug) $226.47
- FARXIGA (Drug) $133.16
- UBRELVY (Drug) $120.06
- Austedo XR (Drug) $111.37
- REXULTI (Drug) $109.09
- LYBALVI (Drug) $99.75
- Axonics (Device) $94.56
- CAPLYTA (Drug) $88.65
- AIRSUPRA (Drug) $72.09
- AMVUTTRA (Drug) $55.56
- Kerendia (Drug) $51.96
- Otezla (Drug) $49.15
- Cologuard Collection Kit (Device) $26.40
- Aimovig (Biological) $23.43
- LEQVIO (Drug) $18.30
- ELIQUIS (Drug) $18.08
- AUSTEDO (Drug) $17.37
- TRINTELLIX (Drug) $14.51
- INGREZZA (Drug) $13.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.